The 2-Minute Rule for QST4
The key conclude level was the security and tolerability of sifalimumab. Remedy-emergent adverse occasions (AEs) and major AEs (SAEs) and their severity, final result, and any connection to the review medication had been recorded because of the investigator all through the study. AEs ended up thought of prone to be related to examine medication whe